Nanjing Medlander Medical Technology Co.,Ltd.

¥25.95As of Sun 8 Nov 2026, 12:00 UTC
SSE:688273Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (1.88%)
Div yield 3.08%
ROE 4.20%
Medical Devices
Beta (5Y) 0.53
PE TTM 39.84
TSR TTM (36.04%)
Mkt cap ¥2.538B
ROIC 5.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
9.82%
(77.78%)
Hold 3|4|7|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.26
0.28
0.31
6.56%
5.81%
19.88%
30.02%
Revenue¥M
133.5
137.9
134.8
131.5
11.74%
11.18%
4.32%
3.67%
Peers (US$380.5M)
Cap (US$)
PE
383.2M
137.7x
Capital
TTM
5Y
10Y
Leveragex
0.962
0.057
0.061
EBIT/Intx
1.797
0.864
0.651
Own earn%
63.84
(140.58)
(110.40)
Sh yield%
52.44
51.23
53.23
Owners
Insiders/Inst%
13.49
56.85
Short interest%
5.36
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
9–15
$1 testx
0.0
Incr. ROIC%
2